(Q46447367)

22 December 2017

title

Prognostic relevance of 'early-onset' graft-versus-host disease following non-myeloablative haematopoietic cell transplantation (English)

1 reference

22 December 2017

17

Rainer Storb

1 reference

22 December 2017

6

Brenda M Sandmaier

1 reference

22 December 2017

9

Thomas R Chauncey

1 reference

22 December 2017

1

Marco Mielcarek

1 reference

22 December 2017

3

Wendy Leisenring

1 reference

22 December 2017

7

David G Maloney

1 reference

22 December 2017

13

Dietger Niederwieser

1 reference

22 December 2017

Judith A Shizuru

10

Judith A Shizuru

1 reference

22 December 2017

Paul J Martin

5

Paul J Martin

1 reference

22 December 2017

Benedetto Bruno

15

Benedetto Bruno

1 reference

22 December 2017

Karl G. Blume

11

Karl G Blume

1 reference

22 December 2017

Ute Hegenbart

12

Ute Hegenbart

1 reference

22 December 2017

Ann E Woolfrey

16

Ann Woolfrey

1 reference

22 December 2017

Stephen J Forman

14

Stephen Forman

1 reference

22 December 2017

Lauri M Burroughs

2

Lauri Burroughs

1 reference

22 December 2017

author name string

Razvan Diaconescu

4

1 reference

22 December 2017

Michael B Maris

8

1 reference

22 December 2017

language of work or name

English

0 references

publication date

1 May 2005

1 reference

22 December 2017

British Journal of Haematology

published in

1 reference

22 December 2017

volume

129

1 reference

22 December 2017

issue

3

1 reference

22 December 2017

page(s)

381-391

1 reference

22 December 2017

Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05458.X

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05458.X

Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05458.X

Measuring comorbidity in older cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05458.X

Comorbidity and Karnofksy performance score are independent prognostic factors in stage III non-small-cell lung cancer: an institutional analysis of patients treated on four RTOG studies. Radiation Therapy Oncology Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05458.X

Safety and efficacy of denileukin diftitox in patients with steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05458.X

Incidence and outcome of cytomegalovirus infections following nonmyeloablative compared with myeloablative allogeneic stem cell transplantation, a matched control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05458.X

Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05458.X

Intrathymic deletion of alloreactive T cells in mixed bone marrow chimeras prepared with a nonmyeloablative conditioning regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05458.X

HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05458.X

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05458.X

Non-myeloablative hematopoietic cell transplantation as immunotherapy for hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05458.X

Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05458.X

Macrophage priming and lipopolysaccharide-triggered release of tumor necrosis factor alpha during graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05458.X

Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbidities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05458.X

Successful use of Campath-1H in the treatment of steroid refractory liver GvHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05458.X

10.1111/J.1365-2141.2005.05458.X

21 January 2018

Identifiers

DOI

1 reference

22 December 2017

release_utzm22t4kvew5ctrgg25ld6rwq

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/utzm22t4kvew5ctrgg25ld6rwq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

22 December 2017